AEMC Harbor AlphaEdge Mid Cap Core ETF
NYSE ARCA · View on SEC EDGAR ↗ 10-K/10-Q May 20, 2026
$20.05
· of 52w range
· above low
· to high
$19.5452w low
$20.3252w high
Revenue
$185
your badges
52W Range
$20–$20
Analyst Rating
·
Price Target
·
P/E
·
ROE
675.7%
Net Profit Margin
-127170.3%
Your badge strip is empty — pin a metric anywhere on this page.
AEMC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$20.05
Revenue
$185
ROE
675.7%
52W Range
$20–$20
AEMC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1852025-06-30 → 2025-06-30
Net margin-127170.3%2025-06-30 → 2025-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | AEMC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -120321.6% | · | · | · | |
| EBITDA Margin | -120321.6% | · | · | · | |
| Net Profit Margin | -127170.3% | · | · | · | |
| ROA | -622.6% | · | · | · | |
| ROE | 675.7%5Y avg ≈231.2% | ≈231.2% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | AEMC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 |
|---|---|---|
| Revenue | $185 | |
| SG&A Expense | $222.8K | |
| Operating Expenses | $222.8K | |
| Operating Income | $-222.6K | |
| Other Non-op | $-12.7K | |
| Net Income | $-235.3K | |
| EBITDA | $-222.6K |
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $9 | |
| Current Assets | $13.1K | |
| Total Assets | $75.6K | |
| Accrued Liabilities | $84.0K | |
| Total Liabilities | $84.0K | |
| Common Stock | $274.7K | |
| Paid-in Capital | $-35.4K | |
| Retained Earnings | $-297.8K | |
| Stockholders' Equity | $-8.4K | |
| Liabilities + Equity | $75.6K | |
| Shares Outstanding | 274,736,005 |
Cash Flow
| Metric | Trend | 2025 |
|---|---|---|
| Operating Cash Flow | $-149.3K | |
| Investing Cash Flow | $-62.5K | |
| Financing Cash Flow | $211.8K | |
| Net Change in Cash | $-21 |
Profitability
| Metric | Trend | 2025 |
|---|---|---|
| Operating Margin | -120321.6% | |
| Net Margin | -127170.3% | |
| EBITDA Margin | -120321.6% | |
| ROA | -622.6% | |
| ROE | 675.7% |
Efficiency
| Metric | Trend | 2025 |
|---|---|---|
| Asset Turnover | 0.0 |
Per Share
| Metric | Trend | 2025 |
|---|---|---|
| Book Value / Share | $0.00 | |
| Cash / Share | $0.00 |
Valuation (TTM)
| Metric | Trend | 2025 |
|---|---|---|
| Revenue TTM | $185 | |
| Net Income TTM | $-235.3K |
Income Statement
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|
| Revenue | $17.5K | · | $44 | $172 | $13 | |
| Cost of Revenue | $8.2K | · | · | · | · | |
| Gross Profit | $9.4K | · | · | · | $13 | |
| SG&A Expense | $19M | $162.7K | $302.9K | $109.6K | $100.6K | |
| Operating Expenses | $19M | $162.7K | $302.9K | $109.6K | $100.6K | |
| Operating Income | $-19M | $-162.7K | $-302.9K | $-109.4K | $-100.6K | |
| Interest Expense | $-375.2K | $-34.7K | $-642.1K | · | · | |
| Other Non-op | $-221.2K | $-635.0K | $-2M | · | · | |
| Net Income | $-19M | · | $-2M | $-122.1K | $-100.6K | |
| EBITDA | $-19M | $-162.7K | $-302.9K | · | $-100.6K |
Balance Sheet
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.3K | $1.2K | $148.1K | $9 | $20.8K | |
| Current Assets | $14.9K | $3.7K | $152.5K | $13.1K | $37.2K | |
| Total Assets | $676.1K | $659.7K | $1M | $75.6K | $37.2K | |
| Accrued Liabilities | $123.0K | $85.0K | $107.0K | $84.0K | $40.0K | |
| Total Liabilities | $889.4K | $1M | $2M | $84.0K | $76.6K | |
| Common Stock | $465.9K | $410.5K | $393.3K | $274.7K | $261.9K | |
| Paid-in Capital | $21M | $2M | $2M | $-35.4K | $-150.6K | |
| Retained Earnings | $-22M | $-3M | $-3M | $-297.8K | $-175.7K | |
| AOCI | · | · | · | · | $-3.0K | |
| Stockholders' Equity | $-213.3K | $-440.9K | $-628.4K | $-8.4K | $-39.4K | |
| Liabilities + Equity | $676.1K | $659.7K | $1M | $75.6K | $37.2K | |
| Shares Outstanding | · | · | · | 274,736,005 | · |
Cash Flow
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $-142.9K | $-182.0K | $-271.2K | $-76.2K | $-60.6K | |
| Investing Cash Flow | $-211.6K | $-210.6K | $-2M | $-43.1K | · | |
| Financing Cash Flow | $359.6K | $245.7K | $2M | $98.4K | $100.8K | |
| Net Change in Cash | $5.1K | $-146.9K | $148.1K | $-20.8K | $20.8K |
Profitability
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|
| Gross Margin | 53.4% | · | · | · | · | |
| Operating Margin | -110180.0% | · | -688384.1% | · | -773930.8% | |
| Net Margin | -110018.1% | · | -5386318.2% | · | -773930.8% | |
| EBITDA Margin | -110180.0% | · | -688384.1% | · | -773930.8% | |
| ROA | -5405.6% | -26.5% | -383.8% | · | -539.9% | |
| ROE | 15260.1% | 34.0% | 679.7% | · | 228.6% |
Liquidity & Solvency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|
| Interest Coverage | 51.5 | 4.7 | 0.5 | · | · |
Efficiency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | · | 0.0 |
Valuation (TTM)
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|
| Net Income TTM | · | $-3M | $-3M | · | $-125.7K |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Revenue | $185 | · | · | · | · |
| Operating Margin % | -120321.6% | · | · | · | · |
| Net Income | $-235.3K | $-30.0K | $-18.5K | $-8.4K | $-5.6K |
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed May 20, 2026